Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humans
- 24 April 2013
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today: Technologies
- Vol. 10 (3), e329-e342
- https://doi.org/10.1016/j.ddtec.2013.03.003
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- The cognitive cost of sleep lostNeurobiology of Learning and Memory, 2011
- Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse modelsBrain Research, 2010
- Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic reviewJournal of Neural Transmission, 2009
- Astrocytic Modulation of Sleep Homeostasis and Cognitive Consequences of Sleep LossNeuron, 2009
- Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's‐disease‐model transgenic mice shown as by micromagnetic resonance imagingJournal of Neuroscience Research, 2008
- Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and healthBrain, 2007
- Functional neuroimaging and behavioral correlates of capacity decline in visual short-term memory after sleep deprivationProceedings of the National Academy of Sciences of the United States of America, 2007
- Prefontal cortex in long-term memory: an “interference” approach using magnetic stimulationNature Neuroscience, 2001
- Isocapnic hypoxemia and neuropsychological functioningJournal of Clinical and Experimental Neuropsychology, 1989
- The effects of hypoxia on reaction time and movement time components of a perceptual—motor taskErgonomics, 1987